N. Bulkmans

发表

Primary hrHPV testing in cervical screening: the arguments

N. Bulkmans, 2008 .

Clonality analysis of pulmonary tumors by genome-wide copy number profiling

B. Ylstra, E. Smit, E. Thunnissen, 2019, PloS one.

Old dilemma: asthma with irreversible airway obstruction or COPD

D. Postma, J. Vonk, N. T. ten Hacken, 2015, Virchows Archiv.

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

P. Snijders, L. Rozendaal, F. Voorhorst, 2005, British Journal of Cancer.

Interobserver, intraobserver, and interlaboratory variability in reporting pT4a colon cancer

H. Grabsch, I. Nagtegaal, A. Karrenbeld, 2019, Virchows Archiv.

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.

J. Cuzick, J. Berkhof, G. Kenter, 2012, The Lancet. Oncology.

The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer.

M. J. van de Vijver, E. Thunnissen, E. Bloemena, 2022, Lung cancer.

POBASCAM, a population‐based randomized controlled trial for implementation of high‐risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women

P. Snijders, M. van Ballegooijen, M. Boon, 2004, International journal of cancer.

High-risk HPV type-specific clearance rates in cervical screening

J. Berkhof, P. Snijders, P. Snijders, 2007, British Journal of Cancer.

Painful Metastasis in the Lunate Bone as the First Symptom of a Pancoast Tumor; a Case Report and Review of the Literature

M. Maas, M. Kreulen, N. Bulkmans, 2015, Journal of Hand and Microsurgery.

High‐risk human papillomavirus DNA load in a population‐based cervical screening cohort in relation to the detection of high‐grade cervical intraepithelial neoplasia and cervical cancer

J. Berkhof, P. Snijders, A. Hesselink, 2009, International journal of cancer.

Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis

J. Berkhof, P. Snijders, M. D. de Bruijne, 2006, International journal of cancer.

Human Papillomavirus Type–Specific 18-Month Risk of High-Grade Cervical Intraepithelial Neoplasia in Women with a Normal or Borderline/Mildly Dyskaryotic Smear

J. Berkhof, C. Meijer, P. Snijders, 2006, Cancer Epidemiology Biomarkers & Prevention.

Risk of high‐grade cervical intra‐epithelial neoplasia based on cytology and high‐risk HPV testing at baseline and at 6‐months

J. Berkhof, C. Meijer, P. Snijders, 2007, International journal of cancer.

Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate

P. Snijders, L. Rozendaal, A. Boeke, 2006, Journal of Clinical Pathology.

Prevalence of types 16 and 33 is increased in high‐risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

J. Berkhof, P. Snijders, F. Voorhorst, 2005, International journal of cancer.

Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands

J. Berkhof, P. Snijders, P. Snijders, 2005, British Journal of Cancer.